Results 11 to 20 of about 63,877 (297)

Cyclooxygenase-2 inhibitors: promise or peril? [PDF]

open access: yesMediators of Inflammation, 2002
The discovery of two isoforms of the cyclooxygenase enzyme, COX-1 and COX-2, and the development of COX-2-specific inhibitors as anti-inflammatories and analgesics have offered great promise that the therapeutic benefits of NSAIDs could be optimized ...
Laurel J. Mengle-Gaw   +1 more
doaj   +2 more sources

Neurobiology and Therapeutic Potential of Cyclooxygenase-2 (COX-2) Inhibitors for Inflammation in Neuropsychiatric Disorders [PDF]

open access: yesFrontiers in Psychiatry, 2019
Neuropsychiatric disorders, such as depression, bipolar disorder, schizophrenia, obsessive-compulsive disorder, and neurodevelopmental disorders such as autism spectrum disorder, are associated with significant illness burden.
Rickinder Sethi   +14 more
doaj   +2 more sources

Discovery of potential cyclooxygenase inhibitors using in silico docking studies [PDF]

open access: yesBangladesh Journal of Pharmacology, 2012
This study deals with the evaluation of the cyclooxygenase inhibitory activity of flavonoids (tangeritin, morin, rhamnetin, theaflavin, pachypodol, eriodictyol, homoeriodictyol, aromadedrin, okanin) using in silico docking studies.
Arumugam Madeswaran   +5 more
doaj   +2 more sources

Cyclooxygenase inhibitors potentiate receptor tyrosine kinase therapies in bladder cancer cells in vitro. [PDF]

open access: yesDrug Des Devel Ther, 2018
Jennifer Bourn,1,2 Maria Cekanova1,2 1Department of Small Animal Clinical Sciences, College of Veterinary Medicine, The University of Tennessee, Knoxville, TN, USA; 2UT-ORNL Graduate School of Genome Science and Technology, The University of Tennessee ...
Bourn J, Cekanova M.
europepmc   +2 more sources

Role of Selective Cyclooxygenase-2 Inhibitors in Renal Colic Pain Reduction and Improvement: A Systematic Review of Clinical Trials [PDF]

open access: yes, 2023
Renal colic is an irritating condition that develops after obstruction of the ureter. Selective cyclooxygenase-2 inhibitors are types of non-steroidal anti-inflammatory drugs (NSAIDs) that have beneficial role in treatment various diseases.
Mohammadian Amiri, Mehdi   +6 more
core   +2 more sources

Efficacy and safety of cyclooxygenase 2 inhibitors for desmoid tumor management: a systematic review [PDF]

open access: yes, 2021
The efficacy and safety of cyclooxygenase 2 (COX2) inhibitors for the treatment of desmoid-type fibromatosis (DF) are unclear. Therefore, we systematically reviewed related literature to assess the efficacy and safety of COX2 inhibitors for DF treatment.
Yoshida, Masahiro   +4 more
core   +1 more source

Treatment with paracetamol, ketorolac or etoricoxib did not hinder alveolar bone healing: a histometric study in rats

open access: yesJournal of Applied Oral Science, 2010
Prostaglandins control osteoblastic and osteoclastic function under physiological or pathological conditions and are important modulators of the bone healing process.
Ricardo Nogueira Fracon   +3 more
doaj   +1 more source

Selective COX-2 inhibitors and risk of myocardial infarction [PDF]

open access: yes, 2005
Selective inhibitors of cyclooxygenase- 2 ( COX- 2, ` coxibs') are highly effective anti-inflammatory and analgesic drugs that exert their action by preventing the formation of prostanoids.
Sohn, Hae-Young   +3 more
core   +1 more source

Cyclooxygenase (COX) Inhibitors and the Newborn Kidney

open access: yesPharmaceuticals, 2012
This review summarizes our current understanding of the role of cyclo-oxygenase inhibitors (COXI) in influencing the structural development as well as the function of the developing kidney.
Wei Qi   +3 more
doaj   +1 more source

New Cyclooxygenase Inhibitors

open access: yesAnnals of the Academy of Medicine, Singapore, 2001
Introduction: The discovery of the two isoforms of cyclooxygenase (COX-1 and COX-2) has paved the way for the development of a new class of non-steroidal anti-inflammatory drugs (NSAIDs). The COX-2 inhibitors have shown comparable efficacy to the traditional NSAIDs with less gastrointestinal side effects in major clinical studies.
S, Vasoo, S C, Ng
openaire   +2 more sources

Home - About - Disclaimer - Privacy